Trademark: 79345349
Word
ELLENNBE
Status Date
Wednesday, September 11, 2024
Filing Date
Friday, February 25, 2022
Published for Opposition
Tuesday, October 15, 2024
5 Dressings, medical; adhesive skin patches for medical use; heating patches for medical purposes; adhesive plasters for medical purposes; pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of autoimmune disorders and autoimmune diseases
45 Licensing of patents; granting of licenses to others for the use of industrial property rights and copyright; licensing of intellectual property; licensing of patents, computer software and intellectual property in the field of technology
10 Hypodermic injection apparatus, namely, hypodermic syringes and hypodermic needles filled with immunomodulatory drugs or peripheral blood mononuclear cells
42 Research and development of vaccines and medicines; bacteriological research and analysis; biological research, clinical research, namely, medical and scientific research in the nature of conducting clinical trials for others, and medical research; pharmaceutical products development; biological research; biochemical analysis; biological analysis; laboratory research services relating to dermatology; pharmaceutical drug development services; research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development of new products; research and development services in the field of antibodies; research relating to biotechnology; research to develop new products; biological research and analysis; biomedical research services; design and product development of medical technology; design and development of medical technology, namely, software design and development for medical technology; scientific research in the field of pharmacy; product development of pharmaceutical preparations and medicines; pharmaceutical research services; biotechnological research relating to livestock, namely, research in the field of gene editing technology and biological research in the field of livestock; pharmaceutical research and development; bacteriological analysis; medical research; development of new products; biochemical research and analysis; research on the subject of pharmaceuticals; biological analysis in the field of molecular biology; none of the foregoing services related to lasers, laser medicine, or laser medical research
Jul 21, 2022
Sn Assigned For Sect 66a Appl From Ib
Jul 22, 2022
New Application Office Supplied Data Entered
Jul 26, 2022
Application Filing Receipt Mailed
Dec 9, 2022
Assigned To Examiner
Dec 13, 2022
Non-Final Action Written
Dec 14, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 8, 2023
Refusal Processed By Mpu
Feb 8, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Feb 11, 2023
Change Of Owner Received From Ib
Feb 26, 2023
New Representative At Ib Received
Mar 6, 2023
Refusal Processed By Ib
May 19, 2023
Teas Change Of Owner Address Received
May 19, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 19, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 19, 2023
Teas Change Of Domestic Representatives Address
May 19, 2023
Teas Change Of Correspondence Received
May 19, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Response To Office Action Received
Aug 2, 2023
Correspondence Received In Law Office
Aug 2, 2023
Teas/Email Correspondence Entered
Dec 27, 2023
Notification Of Possible Opposition Sent To Ib
Aug 9, 2023
Suspension Letter Written
Aug 9, 2023
Letter Of Suspension E-Mailed
Aug 9, 2023
Notification Of Letter Of Suspension E-Mailed
Feb 14, 2024
Suspension Checked - To Attorney For Action
Dec 27, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 13, 2024
Notification Of Possible Opposition - Processed By Ib
Feb 27, 2024
Non-Final Action E-Mailed
Feb 27, 2024
Non-Final Action Written
Feb 27, 2024
Notification Of Non-Final Action E-Mailed
Aug 26, 2024
Teas/Email Correspondence Entered
Aug 26, 2024
Correspondence Received In Law Office
Aug 26, 2024
Teas Response To Office Action Received
Sep 9, 2024
Approved For Pub - Principal Register
Sep 25, 2024
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
